Apelian David

Avg. Two Year Performance

No purchase track record
73% Avg. Sale Return
31% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return36%28%29%61%73%
Sale Success Rate1 of 11 of 11 of 11 of 11 of 1
Drugs » Biotechnology

CEO, Director:

Holdings: 11.0K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Biotechnology

Chief Medical Officer:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--